We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Australia’s Therapeutic Goods Administration is abandoning its goal of 15-day timelines to process GMP clearance filings from overseas manufacturers. Read More
The U.S. Senate Committee on Health, Education, Labor and Pensions postponed a Wednesday vote on the nomination of Scott Gottlieb to be the next commissioner of the FDA. Read More
Divi’s Laboratories has been warned by the FDA for failing to meet current good manufacturing practice requirements, adding to the Indian drug manufacturer’s compliance woes. Read More